BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15336982)

  • 1. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy.
    Takamori M
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1347-51. PubMed ID: 15336982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambert-Eaton myasthenic syndrome as an autoimmune calcium-channelopathy.
    Takamori M; Maruta T; Komai K
    Neurosci Res; 2000 Mar; 36(3):183-91. PubMed ID: 10683522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
    Takamori M; Komai K; Iwasa K
    Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome.
    Takamori M
    Intern Med; 1999 Feb; 38(2):86-96. PubMed ID: 10225662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical approaches to neuromuscular junction disorders].
    Takamori M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1363-4. PubMed ID: 9128412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lambert-Eaton myasthenic syndrome].
    Takamori M
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1903-11. PubMed ID: 9788200
    [No Abstract]   [Full Text] [Related]  

  • 12. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
    J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lambert-Eaton myasthenic syndrome and myasthenia gravis].
    Takamori M; Iwasa K; Komai K; Yasukawa Y
    No To Shinkei; 1997 Dec; 49(12):1089-100. PubMed ID: 9453039
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated dysphagia due to paraneoplastic myasthenic syndrome with anti-P/Q-type voltage-gated calcium-channel and anti-acetylcholine receptor antibodies.
    Fernandez-Torron R; Arcocha J; López-Picazo JM; Pardo J; Tamura MA; Carretero C; Pastor P
    Neuromuscul Disord; 2011 Feb; 21(2):126-8. PubMed ID: 21115345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
    Martin-Moutot N; De Haro L; Seagar M
    J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
    Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
    Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lambert-Eaton myasthenic syndrome].
    Sakai K
    Ryoikibetsu Shokogun Shirizu; 2000; (31):56-8. PubMed ID: 11269163
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Komai K; Iwasa K; Takamori M
    J Neurol Sci; 1999 Jul; 166(2):126-30. PubMed ID: 10475106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.